본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies Kim Ho Jin
(Immuno-oncology Branch)


()
. Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2025-05-02; 2025; 12(8):1689~1692. IF 3.9 (2024)
Mortality Risk According to Changes in Alcohol Consumption Post-Diagnosis Among Liver Cancer Patients Oh J K
(Department of Public Health & AI)

Thi Tra BUI
(Department of Public Health & AI)
. Mortality Risk According to Changes in Alcohol Consumption Post-Diagnosis Among Liver Cancer Patients. LIVER INTERNATIONAL. 2025-05-02; 2025; 45(6):e70120~. IF 5.2 (2024)
Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria Kang Sokbom
(Center for Uterine Cancer)

Bae Jae Kyung
(Department of Obstetrics and Gynecology)
. Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria. GYNECOLOGIC ONCOLOGY. 2025-04-30; 2025; 197:91~95. IF 4.1 (2024)
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease Kim Ho Jin
(Immuno-oncology Branch)

Kang You Ri
(Department of Neurology)
. Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease. MULTIPLE SCLEROSIS JOURNAL. 2025-04-28; 2025; 31(9):1102~1109. IF 5 (2024)
Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: A systematic review and network meta-analysis Kim Jeong seon
(Department of Cancer Biomedical Science)

Hoang Tung
(Department of Cancer AI and Digital Health)
. Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: A systematic review and network meta-analysis. INTERNATIONAL JOURNAL OF CANCER. 2025-04-28; 2025; 157(4):722~740. IF 4.7 (2024)
Neurologic symptoms as a hallmark of glymphatic alteration in recovered patients with COVID-19 Seo Ji Won
(Department of Radiology)


()
. Neurologic symptoms as a hallmark of glymphatic alteration in recovered patients with COVID-19. BMC NEUROLOGY. 2025-04-28; 2025; 25:187~. IF 2.2 (2024)
The Impact of Advanced Care Planning on Hospice Utilization in Patients with Cancer: A Nationwide Analysis in Korea Choi Jinyoung
(National Hospice Center)

Kim Woo Rim
(Hospice Policy & Planning Team)
. The Impact of Advanced Care Planning on Hospice Utilization in Patients with Cancer: A Nationwide Analysis in Korea. CANCERS. 2025-04-27; 2025; 17(9):1471~. IF 4.4 (2024)
Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers Joung, Jae Young
(Targeted Therapy Branch)


()
. Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers. BIOMOLECULES. 2025-04-27; 2025; 15(5):625~. IF 4.8 (2024)
Regional population decline and health screening uptake in Korean adults: nationwide study using multilevel regression analysis Han Kyu Tae
(Division of Cancer Management Policy)

Jeong Won Jeong
(Cancer Information & Education Center)
. Regional population decline and health screening uptake in Korean adults: nationwide study using multilevel regression analysis. FRONTIERS IN PUBLIC HEALTH. 2025-04-25; 2025; 13:1507691~. IF 3.4 (2024)
Ultrafine Particle Mobile Monitoring Study Designs for Epidemiology: Cost and Performance Comparisons Kim, Sun-Young
(Department of Public Health & AI)

Kim, Sun-Young
(Department of Public Health & AI)
. Ultrafine Particle Mobile Monitoring Study Designs for Epidemiology: Cost and Performance Comparisons. ENVIRONMENTAL HEALTH PERSPECTIVES. 2025-04-23; 2025; 133(3-4):47010~. IF 9.8 (2024)